A study published in Lancet Neurology reported that PD patients carrying LRRK2 mutations exhibit significantly increased cholinesterase activity in the cortex, limbic system, and thalamus compared to sporadic PD cases [51]. Here, LRRK2 is linked to Parkinson disease.